Novartis | NVS - ДОЛГ





ДОЛГ Изменить Дата
AbbVie USD 70.82B 2.04B 2026-06
Amgen USD 57.3B 19M 2026-06
AstraZeneca USD 32.24B 1.68B 2026-06
Bausch Health Companies USD 20.72B 64M 2026-09
Biogen USD 7.69B 398.3M 2026-09
Bristol-Myers Squibb USD 42.88B 2.18B 2026-09
Canopy Growth CAD 277.33M 1.38M 2026-06
Corcept Therapeutics USD 8.99M 430K 2026-09
Drreddys Laboratories INR 72.29B 5.05B 2026-09
Eli Lilly USD 54.91B 11.54B 2026-06
Gilead Sciences USD 26.25B 4.07B 2026-06
GlaxoSmithKline GBP 18.24B 818M 2026-06
Glaxosmithkline GBP 23.7B 4.65B 2026-09
J&J USD 49.04B 5.95B 2026-06
Merck USD 53.91B 4.79B 2026-06
Novartis USD 49.01B 2.02B 2026-06
Novartis USD 48.31B 1.31B 2026-09
Pacira USD 293.59M 69.53M 2026-09
Perrigo USD 3.29B 337.7M 2026-06
Pfizer USD 62.67B 523M 2026-09
Phibro Animal Health USD 474.17M 730K 2024-09
Prestige Brands USD 2.07B 1.02B 2026-06
Roche Holding CHF 33.03B 1.41B 2025-06
Sanofi EUR 23.58B 3.56B 2026-06
Sanofi EUR 23.58B 3.56B 2026-06
Supernus Pharmaceuticals USD 40.17M 733K 2026-06
Zoetis USD 9.24B 0 2026-06